Connect with us

Hi, what are you looking for?

Jewish Business News

Money

Tower Semiconductor Share Price Jump on Jim Cramer Recommendation

Jim Cramer advises tracking the share in his “4 Under-$10 High Tech Stocks to Watch.”
Celebrities Visit SiriusXM Studios - September 25,    2013
Jim Cramer / Getty

The share price of specialty foundry Tower Semiconductor Ltd. (Nasdaq:TSEM; TASE: TSEM) rose 6.1% on Nasdaq on Wednesday to $6.30, giving a market cap of $293 million. The share rose 10.7% on the TASE yesterday, but is down 0.4% in morning trading on the TASE today to NIS 21.60, after Jim Cramer advised tracking the share in his “4 Under-$10 High Tech Stocks to Watch.”Cramer says, “From a technical perspective, Tower spiked higher here right above some near-term support at $5.44 and above its 200-day at $5.26 with strong upside volume. This move is quickly pushing shares of Tower within range of triggering a major breakout trade. That trade will hit if Tower manages to take out Tuesday’s high of $5.99 to some more key overhead resistance at $6.11 with high volume.

“Traders should now look for long-biased trades in TSEM as long as it’s trending above Thursday’s low of $5.58 or above its 200-day at $5.26 and then once it sustains a move or close above those breakout levels with volume that hits near or above 155, 068 shares. If that breakout triggers soon, then TSEM will set up to re-test or possibly take out its next major overhead resistance levels $7.53 to its 52-week high at $8.67.

Published by Globes [online], Israel business news – www.globes-online.com 

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

empty

The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

Business

Now Platika joins and elite club of $10 billion plus Israeli firms.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

Advertisement